Mycoplasma pneumoniae pneumonia in the elderly

Medical Science Monitor

Volumn 14, Issue 8, 2008, Pages

  Miyashita, Naoyuki ^a,b   Ouchi, Kazunobu ^a   Kawasaki, Kozo ^a   Oda, Keiko ^a   Kawai, Yasuhiro ^a   Shimizu, Hiroki ^a   Kobashi, Yoshihiro ^a   Oka, Mikio ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b Division of Respiratory Diseases   (Japan)

Author keywords

Community acquired pneumonia; Elderly; Guidelines; Mycoplasma pneumoniae

Indexed keywords

BETA LACTAM; MACROLIDE; MINOCYCLINE; QUINOLONE DERIVATIVE;

ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEVER; GROUPS BY AGE; HOSPITAL PATIENT; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MORBIDITY; MYCOPLASMA PNEUMONIAE; PNEUMONIA; PRACTICE GUIDELINE; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADULT; AGE DISTRIBUTION; AGED; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; JAPAN; MALE; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA;

EID: 50249097667     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Waites KB, Talkington DF: Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev, 2004; 17: 697-728
2. Arnold FW, Summersgill JT, Lajoie AS et al: A worldwide perspective of atypical pathogens in community-acquired pneumonia. Am J Respir Crit Care Med, 2007; 175: 1086-93
3. Miyashita N, Fukano H, Mouri K et al: Community-acquired pneumonia in Japan: a prospective ambulatory and hospitalised patient study J Med Microbiol, 2005; 54: 395-400
4. National Institute of Health. Infectious Disease Surveillance Center. Mycoplasma pneumoniae pneumonia. http://idsc.nih.go.jp/idwr/kanja/ weeklygraoh/18myco.html
5. Goto H, Takeda H, Kawai S et al: Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004). Jpn J Antibiotic, 2006; 59: 323-54
6. Song JH, Jung SI, Ko KS et al: High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother, 2004; 48: 2101-7
7. Inoue M, Lee NY, Hong SW et al: PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int J Antimicrob Agents, 2004; 23: 44-51
8. Yokota S, Sato K, Kuwahara O et al: Fluoroquinolone-resistant Streptococcus pneumoniae strains occur frequency in elderly patients in Japan. Antimicrob Agents Chemother, 2002; 46: 3311-15
9. The committee for the JRS guidelines in management of respiratory infections. The JRS guidelines for the management of community-acquired pneumonia in adults [in Japanese]. In: Matsushima, T, Kohno S, Saito A et al. Eds. The Japanese Respiratory Society. Tokyo, Japan, 2005
10. Woodhead M: Pneumonia in the elderly. J Antimicrob Chemother, 1994; 34(Suppl.A): 85-92
11. Ruiz M, Ewig S, Marcos MA et al: Etiology of community-acquired pneumonia: impact if age, comorbidity, and severity. Am J Respir Crit Care Med, 1999; 160: 397-405
12. Lim WS, Macfarlane JT, Boswell TCJ et al: Study of community-acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax, 2001; 56: 296-301
13. Jokinen C, Heiskanen L, Juvonen H et al: Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis, 2001; 32: 1141-54
14. Huang HH, Zhang YY, Xiu QY et al: Community-acquired pneumonia in Shanghai, China: microbial etiology and implications for empirical therapy in a prospective study of 389 patients. Eur J Clin Microbiol Infect Dis, 2006; 25: 369-74
15. Saito A, Kohno S, Matsushima T et al: Prospective multicenter study of the causative organisms of community-acquired pneumonia in adults in Japan. J Infect Chemother, 2006; 12: 63-69
16. Ishida T, Hashimoto T, Arita M, Ito I, Osawa M: Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest, 1998; 114: 1588-93
17. Miyashita N, Fukano H, Okimoto N et al: Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest, 2002; 121: 1776-81
18. Ishida T, Miyashita N, Nakahama C: Clinical differentiation of atypical pneumonia using Japanese guidelines. Respirology, 2007; 12: 104-10
19. Miyashita N, Fukano H, Yoshida K et al: Is it possible to distinguish between atypical pneumonia and bacterial pneumonia ?: evaluation of the guidelines for community-acquired pneumonia in Japan. Respir Med, 2004; 98: 952-60
20. Fine MJ, Auble TE, Yealy DM et al: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med, 1997; 336: 243-50
21. Marrie TJ: Mycoplasma pneumoniae pneumonia requiring hospitalization, with emphasis on infection in the elderly. Arch Intern Med, 1993; 153: 488-94
22. Marrie TJ, Haldane EV, Faulkner RS et al: Community-acquired pneumonia requiring hospitalization: is it different in the elderly? J Am Geriatr Soc, 1985; 33: 671-80
23. Metlay JP, Schulz R, Li YH et al: Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med, 1997; 157: 1453-59